Programa Orion - MCK

REFERENCIAS

1. Stoekenbroek RM, Kallend D, Wijngaard PL, Kastelein JJ. Inclisiran for the treatment of cardiovascular disease: the ORION clinical development program. Future Cardiol. 2018 Nov;14(6):433-442. doi: 10.2217/fca-2018-0067. Epub 2018 Oct 30. PMID: 30375244.
2. Ray K, Wright R, Kallend D, et al. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N Engl J Med. 2020;382(16):1507-1519.
3. Novartis (2023). Información Para Prescribir Amplia Sybrava®
4. R. Scott Wright, MD, FACC. Inclisiran for Subjects With ASCVD and Elevated Low Density Lipoprotein Cholesterol - ORION-10. American College of Cardiology. May 2020.